Nepal | September 30, 2020

Mexico needs 200 million COVID-19 vaccine doses; shots could start in April

Share Now:

MEXICO CITY: Mexico will need up to 200 million coronavirus vaccine doses, according to a senior government official, and inoculation of its 120 million inhabitants could start as early as April if clinical trials and regulatory approvals for pharmaceutical firm AstraZeneca Plc go as planned.

In partnership with the governments of Mexico and Argentina, AstraZeneca initially plans to produce 150 million doses in early 2021 and eventually make at least 400 million doses for distribution throughout Latin America. AstraZeneca is among those working on COVID-19 vaccine candidates now in development around the world.

Mexico’s government also has said it is considering other options for bringing a vaccine quickly to its population, the second-largest in Latin America.

AstraZeneca will be able to produce between 30 and 35 million vaccines per month, Martha Delgado, a Mexican deputy foreign minister, told Reuters in an interview on Friday.

The vaccine could require two doses to be effective, Delgado said.

“If we need 200 million, we’re going to be vaccinating for a long time,” Delgado added.

Last-stage so-called Phase III trials are expected to conclude by November or December, after which AstraZeneca will seek government approvals if the vaccine is found to be safe and effective. If that goes smoothly, Delgado estimated the first vaccines in Mexico could be administered in April.

Mexico’s death toll of 55,908 stands as the world’s third highest, behind the United States and Brazil. Latin America’s 6 million cases and more than 237,000 deaths make it the world’s hardest-hit region.

To ensure all Mexicans have access to a vaccine, President Andres Manuel Lopez Obrador’s government is in talks with other pharmaceutical laboratories in different stages of developing a vaccine.

“Astra’s production isn’t going to be enough for Mexico. We need to supplement that with a couple of more vaccines,” Delgado said.

Mexico’s government has completed memorandums of understanding with French drugmaker Sanofi, Johnson & Johnson’s Janssen unit and Chinese companies CanSino Biologics Inc and Walvax Biotechnology Co Ltd.

CanSino and Walvax are interested in producing a vaccine in Mexico for delivery to the Latin American market.

Mexico’s health authorities are evaluating the Phase I and II clinical trials of those four companies and will determine the viability of Phase III studies in Mexico in the coming weeks, Delgado said. The earlier phase trials represent an initial test of a vaccine’s safety and effectiveness among small numbers of subjects.

To save time, Mexico’s federal health regulator COFEPRIS will start analyzing AstraZeneca’s completed studies and accelerate approvals if Phase III is successful.

“This is the country’s strategy to diversify our possibilities of having access to the vaccine as soon as possible … and obviously at an affordable cost for the country,” Delgado said.

Follow The Himalayan Times on Twitter and Facebook

Recommended Stories:

More from The Himalayan Times:

Two more Covid-19 related fatalities reported in Banke

RANJHA: Two more Covid-19 related deaths have been reported in Banke district on Tuesday. According to Naresh Shrestha, corona resource person at District Health Office, Banke, a 41-year-old man of Ranitalau in Nepalgunj Sub-Metropolitan City-7, and a 53-year-old man of Kohalpur Municipality-10 Read More...

Nepal's coronavirus cases top 75,000 on Tuesday with 1513 infections

KATHMANDU: Nepal’s coronavirus tally moved to 76,258 as 1,513 new infections were reported in the last 24 hours. Read Also: Kathmandu valley registers record-high 934 single-day coronavirus cases As many as 731 people that had earlier contracted Covid-19 tested negative for the infection as Read More...

Ten Covid-19 fatalities recorded, death-toll inches closer closer to 500

KATHMANDU: Ten people passed away from Covid-19 related complications in the last 24 hours, with which the nationwide death-toll has moved to 491. Three women and seven men lost their lives due to this infection, the Health Ministry’s latest update showed. Read Also: Kathmandu valley registe Read More...

Kathmandu valley registers record-high 934 single-day coronavirus cases

KATHMANDU: The number of single-day coronavirus infections detected in the three districts of Kathmandu valley exceeded 900 for the first time on Tuesday. As many as 934 cases surfaced in the valley in the last 24 hours, of which a majority 747 infections were registered in the capital alone. Read More...

Nepal to receive 25 mln Russian Covid-19 vaccine doses

KATHMANDU: Russia is set to supply 25 million doses of its potential Covid-19 vaccine to Nepal. The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund on Tuesday said that it will supply the Russian Sputnik V vaccine through Trinity Pharmaceuticals based in Nepal. The pres Read More...

Liverpool's Klopp bristles at Keane's "sloppy" criticism

LONDON: Liverpool manager Juergen Klopp hit back at television pundit and former Manchester United captain Roy Keane on Monday after the Irishman described the Premier League champions' defending in a 3-1 win over Arsenal on Monday as "sloppy". Liverpool have won all three of their league games s Read More...

Djokovic seeks French Open redemption after New York fiasco

PARIS: Three weeks after an acrimonious exit at the US Open, world number one Novak Djokovic will resume his pursuit of an 18th Grand Slam title when he takes on Sweden's Mikael Ymer in the first round at the French Open on Tuesday. The Serbian had started as a heavy favourite to win the title at Read More...

Youth held for raping minor in Rautahat

RAUTAHAT: A youth has been arrested on the charges of raping a 15-year-old girl in Rauthat, on Monday night. The victim's father filed a first incident report (FIR) against 35-year-old Indal Das at a nearby police station. Subsequently, the accused was apprehended from his house around mid-night Read More...